InvestorsHub Logo
Followers 20
Posts 1716
Boards Moderated 0
Alias Born 09/09/2012

Re: biopharm post# 314904

Saturday, 10/21/2017 11:22:30 AM

Saturday, October 21, 2017 11:22:30 AM

Post# of 345784
They will-once they have the board seats.
All this information becomes available when negotiating the partnership.
No reason to hold anything back at that point.
The irony is, Ronin nominees have more mab experience than the Tustin nominees who used another board expansion for a redundant profile of Lias. An absolute waste and just a last ditch effort to cover the current Board weaknesses.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News